Angiogenin: a review of the pathophysiology and potential clinical applications.
Angiogenin is a member of the ribonuclease (RNase) superfamily: enzymes of innate substrate specificity, but divergent functional capacities. Angiogenin is a normal constituent of the circulation and contained in a vasculature that rarely undergoes proliferation, but in some physiological and pathological conditions its levels increase in blood, promoting neovascularization. Hence, angiogenesis is a common pathophysiological attribute of angiogenin. In malignant disease, the most studied pathological state in regard to angionenin, abnormally high levels are seen, which may be of prognostic significance. Angiogenin has also been studied in other non-malignant pathological states. The aim of this review article is to provide an overview of the biochemistry and physiology of angiogenin, specifically in relation to the human pathological states where angiogenin has been implicated and finally, its potential clinical applications.
Tello-Montoliu
A
A
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.
Patel
J V
JV
Lip
G Y H
GY
D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000175:diagnosis; D009389:Neovascularization, Pathologic / Q000097:blood / Q000209:etiology; D011247:Pregnancy; D011379:Prognosis; D012259:Ribonuclease, Pancreatic / Q000097:blood* / Q000502:physiology
C046366:angiogenin; D012259:Ribonuclease, Pancreatic